商品敘述：

In September 2025, Tom Hale, OURA''s CEO, faces a classic "where to play, how to win" inflection point: the Oura Ring has become a breakout consumer health wearable - profitable, scaling fast, and valued at $5.2B post-money, backed by $770M in venture capital. With roughly $500M of revenue in 2024, growth has been propelled by women''s-health use cases and reimbursement tailwinds. But Hale is now wrestling with what his next strategic move should be. He can keep driving OURA''s proven go-to-market engine for consumer sales, or he can push hard into regulated healthcare, where clinical validation and payer/provider partnerships could unlock a much larger market - but at the cost of longer cycles, new capabilities, and an operating model that risks slowing (or pulling resources from) the core. Hale has to decide how bold OURA should be and what sequencing, go-to-market strategy, and resource allocation would enable him to capture the healthcare upside without breaking the speed, focus, and repeatability that made the company successful in its consumer markets.

涵蓋領域：

Business growth;Diversification;Entrepreneurship;Health and wellness;Healthcare and treatment;Scaling entrepreneurial ventures;Strategy

相關資料：

, (9-826-185), p, by Thomas R. Eisenmann

哪些人也有訂購？